
Andreas Rimner, MD
Radiation Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Lung Cancer, Mesothelioma, Thymic Tumors, Other Thoracic Malignancies, Metastatic Disease, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery, Image- Guided Radiotherapy, Intra-Operative Radiation Therapy
Request an Appointment
About Me
- Director, Thoracic Radiation Oncology Research
I am a radiation oncologist who specializes in caring for people with cancers of the chest, known as thoracic cancers. These include non-small cell and small cell lung cancers, pleural mesotheliomas, thymomas, lung metastases, sarcomas, and other rare tumors of the chest.
I work closely with a highly skilled team of experts from many areas — including surgeons, medical oncologists, radiologists, medical physicists, and radiation therapists — to determine the best treatment options for my patients. We use the most advanced radiation techniques, including stereotactic body radiation therapy (SBRT) or stereotactic ablative body radiation (SABR), stereotactic radiosurgery (SRS), intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), intensity-modulated pleural radiation therapy (IMPRINT), MR-guided radiation therapy, and proton radiation to precisely target cancers while limiting damage to normal tissues.
Read more
When patients first come to see me, my goal is to help them understand how radiation therapy works, what is practically involved, and what potential side effects they may experience. Radiation therapy is a highly individualized, localized treatment option, and the quality of the outcome is highly dependent on the operator designing the radiation treatment. As a localized treatment, similar to surgery, side effects are usually restricted to the area of the body being treated.
As the Director of Thoracic Radiation Oncology Research, I lead a research team with multiple clinical trials to give our patients the most modern and promising treatment options available. I have a particular interest in improving imaging and the precision of radiation treatment delivery for patients with thoracic tumors. Combining radiation therapy with novel drugs, such as immunotherapy and targeted therapies is rapidly advancing the field of thoracic oncology, and we have a large portfolio of clinical trials exploring these multimodality treatments. Lastly, we are conducting multiple studies on predictive biomarkers of outcome, side effects, and patient-reported quality of life with thoracic radiation therapy.
Outside of work, I enjoy traveling, classical music, and hiking.
A radiation oncologist is a cancer doctor with special training in using radiation therapy (RT) to treat cancer with radiation.
My Specialties
- Lung Cancer, Mesothelioma, Thymic Tumors, Other Thoracic Malignancies, Metastatic Disease, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery, Image- Guided Radiotherapy, Intra-Operative Radiation Therapy
Education
- MD, Eberhard-Karls-Universitat Tubingen
Residencies
- Radiation Oncology - Memorial Sloan Kettering Cancer Center
Awards and Honors
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- ITMIG Barbara Neibauer Award (2014)
- IMIG New Young Investigator award (2012)
Board Certifications
- Radiation Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

New Patients
Current Patients
Contact and Location
Dr. Rimner sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all External Beam Radiotherapy Service, Manhattan doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Rimner
- A Phase I Study of Pembrolizumab Immunotherapy and Radiation Therapy in People with Inoperable Pleural Mesothelioma
- A Phase II Study of Durvalumab Immunotherapy and Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
- A Phase II Study to See if Durvalumab with Concurrent Radiation Therapy Can Prevent the Growth of Non-Small Cell Lung Cancer
- A Phase III Study Assessing the Addition of Radiation Therapy to Surgery and Chemotherapy to Treat Malignant Pleural Mesothelioma
Read more
- Clinical Trials Co-Investigated by Dr. Rimner
- A Phase II Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People with Thymic Cancer that Has Spread to the Lining of the Lungs and Chest

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Rimner’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Andreas Rimner discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities -
International Mesothelioma Interest Group
Fiduciary Role / Position
-
International Thymic Malignancy Interest Group (ITMIG)
Fiduciary Role / Position -
Merck & Co Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].